Michigan 2025-2026 Regular Session

Michigan Senate Bill SB0033

Introduced
2/4/25  
Refer
2/4/25  
Report Pass
3/20/25  
Refer
3/20/25  
Report Pass
4/16/25  

Caption

Probate: patient advocates; withholding life-sustaining treatment for a patient who is pregnant; allow. Amends secs. 5507 & 5509 of 1998 PA 386 (MCL 700.5507 & 700.5509).

Impact

The legislation is expected to influence the way medical decisions are made for pregnant patients who are unable to express their wishes due to incapacity. It allows for more explicit directives concerning life-sustaining treatment preferences and anatomical gifts. By granting patient advocates the authority to act in accordance with the expressed wishes of the patient, the bill aims to balance the need for medical interventions against the autonomy of those who cannot participate in their care decisions during critical periods. It delineates the responsibilities and limitations of patient advocates to provide clear guidance to both advocates and healthcare providers.

Summary

Senate Bill 33 seeks to amend certain sections of the Estates and Protected Individuals Code in Michigan, particularly relating to patient advocate designations. The bill enables patients to articulate their preferences regarding medical treatment and other decisions at the time the advocate designation becomes effective, especially if the patient is pregnant. It emphasizes that a patient's pregnancy status does not diminish their rights to express desires concerning care, custody, and treatment. Furthermore, it provides clarity on the power of patient advocates regarding life-sustaining treatments and anatomical gifts, aimed at ensuring that patient wishes are honored even in delicate scenarios involving pregnancy.

Sentiment

Overall, the sentiment towards SB 33 appears to be generally supportive among those who prioritize patient autonomy. Proponents appreciate the clarity it provides in advocating for patients’ rights, especially in cases involving pregnant individuals. However, there may be concerns regarding the practical implications of allowing advocates to make crucial decisions that may affect both the mother and fetus, which could lead to discussions surrounding ethical considerations in the medical community.

Contention

Notable points of contention surrounding the bill could arise from its provisions concerning the withholding of life-sustaining treatment from pregnant patients. Although the bill aims to protect the rights and desires of patients, there are ethical dilemmas regarding the timing and nature of such interventions when the health of both the mother and unborn child is at stake. Critics may argue that this bill could lead to difficult moral decisions for patient advocates, especially regarding how to navigate conflicting medical advice or circumstances of emergency treatment.

Companion Bills

No companion bills found.

Similar Bills

MI SB0031

Health facilities: hospitals; certain policies on patients who are giving birth; require a hospital to adopt. Amends secs. 20201 & 21513 of 1978 PA 368 (MCL 333.20201 & 333.21513) & adds sec. 21537.

NM HB424

Pregnancy & Family Care Act

TX SB2199

Relating to protection of individuals from participation in a health care service for reasons of conscience; providing a civil remedy; authorizing disciplinary action.

TX SB16

Relating to protection of individuals from participation in a health care service for reasons of conscience; providing a civil remedy; authorizing disciplinary action.

TX SB34

Relating to protection of individuals from participation in a health care service for reasons of conscience; providing a civil remedy; authorizing disciplinary action.

TX SB17

Relating to protection of individuals from participation in a health care service for reasons of conscience; providing a civil remedy; authorizing disciplinary action.

TX SB1674

Relating to protection of individuals from participation in a health care service for reasons of conscience; providing a civil remedy; authorizing disciplinary action.

TX HB3318

Relating to access to individualized investigational treatments for patients with life-threatening or severely debilitating illnesses.